E. Hiltbold, P. Ciborowski, O. Finn (1998)
Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells.Cancer research, 58 22
J. Galon, W. Fridman, F. Pagès (2007)
The adaptive immunologic microenvironment in colorectal cancer: a novel perspective.Cancer research, 67 5
A. Vlad, J. Kettel, Nehad Alajez, C. Carlos, O. Finn (2004)
MUC1 immunobiology: from discovery to clinical applications.Advances in immunology, 82
O. Finn (2003)
Cancer vaccines: between the idea and the realityNature Reviews Immunology, 3
J. Gulley, P. Arlen, K. Tsang, Junko Yokokawa, C. Palena, D. Poole, C. Remondo, V. Cereda, J. Jones, M. Pazdur, J. Higgins, J. Hodge, S. Steinberg, H. Kotz, W. Dahut, J. Schlom (2008)
Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic CarcinomaClinical Cancer Research, 14
V. Karanikas, L. Hwang, J. Pearson, C. Ong, V. Apostolopoulos, H. Vaughan, P. Xing, G. Jamieson, G. Pietersz, B. Tait, Russell Broadbent, G. Thynne, I. Mckenzie (1997)
Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.The Journal of clinical investigation, 100 11
M. Caskey, F. Lefebvre, A. Filali‐Mouhim, M. Cameron, J. Goulet, E. Haddad, Gaëlle Breton, C. Trumpfheller, S. Pollak, I. Shimeliovich, Angela Duque-Alarcón, Li Pan, Annette Nelkenbaum, A. Salazar, S. Schlesinger, R. Steinman, R. Sékaly (2011)
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humansThe Journal of Experimental Medicine, 208
D. Cramer, O. Finn (2011)
Epidemiologic perspective on immune-surveillance in cancer.Current opinion in immunology, 23 2
D. Cramer, L. Titus-Ernstoff, J. McKolanis, W. Welch, A. Vitonis, R. Berkowitz, O. Finn (2005)
Conditions Associated with Antibodies Against the Tumor-Associated Antigen MUC1 and Their Relationship to Risk for Ovarian CancerCancer Epidemiology Biomarkers & Prevention, 14
G. Rowse, R. Tempero, M. VanLith, M. Hollingsworth, S. Gendler (1998)
Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model.Cancer research, 58 2
S. Gendler, J. Burchell, T. Duhig, D. Lamport, R. White, M. Parker, J. Taylor‐Papadimitriou (1987)
Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium.Proceedings of the National Academy of Sciences of the United States of America, 84 17
M. Cheever, J. Allison, A. Ferris, O. Finn, Benjamin Hastings, T. Hecht, I. Mellman, S. Prindiville, J. Viner, L. Weiner, L. Matrisian (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational ResearchClinical Cancer Research, 15
B. Acres, V. Apostolopoulos, J. Balloul, D. Wreschner, P. Xing, D. Ali-Hadji, N. Bizouarne, M. Kieny, I. Mckenzie (2000)
MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccinesCancer Immunology, Immunotherapy, 48
O. Finn (2003)
Premalignant Lesions as Targets for Cancer VaccinesThe Journal of Experimental Medicine, 198
P. Singh, M. Hollingsworth (2006)
Cell surface-associated mucins in signal transduction.Trends in cell biology, 16 9
A. Lepisto, A. Moser, H. Zeh, K. Lee, D. Bartlett, J. McKolanis, B. Geller, A. Schmotzer, D. Potter, T. Whiteside, O. Finn, R. Ramanathan (2008)
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.Cancer therapy, 6 B
A. Montero, C. Diaz-Montero, C. Kyriakopoulos, V. Bronte, S. Mandruzzato (2012)
Myeloid-derived Suppressor Cells in Cancer Patients: A Clinical PerspectiveJournal of Immunotherapy, 35
D. Barnd, Michael Lan, R. Metzgar, O. Finn (1989)
Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.Proceedings of the National Academy of Sciences of the United States of America, 86 18
C. Melief, O. Finn (2011)
Cancer immunology.Current opinion in immunology, 23 2
Sean Ryan, M. Turner, J. Gariépy, O. Finn (2010)
Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses.Cancer research, 70 14
P. Maisonneuve, E. Botteri, A. Lowenfels (2008)
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps.Gastroenterology, 135 2
I. Poschke, Yumeng Mao, L. Adamson, F. Salazar-Onfray, G. Masucci, R. Kiessling (2012)
Myeloid-derived suppressor cells impair the quality of dendritic cell vaccinesCancer Immunology, Immunotherapy, 61
S. Zotter, A. Lossnitzer, P. Hageman, J. Delemarre, J. Hilkens, J. Hilgers (1987)
Immunohistochemical localization of the epithelial marker MAM-6 in invasive malignancies and highly dysplastic adenomas of the large intestine.Laboratory investigation; a journal of technical methods and pathology, 57 2
Y. Kotera, Fontenot Jd, G. Pecher, Metzgar Rs, O. Finn (1994)
Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.Cancer research, 54 11
B. Levin, D. Lieberman, B. McFarland, Robert Smith, D. Brooks, Kimberly Andrews, C. Dash, F. Giardiello, S. Glick, T. Levin, Perry Pickhardt, D. Rex, A. Thorson, S. Winawer (2008)
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * †CA: A Cancer Journal for Clinicians, 58
R. Ramanathan, K. Lee, J. McKolanis, Elizabeth Hitbold, W. Schraut, A. Moser, Elizabeth Warnick, T. Whiteside, J. Osborne, H. Kim, R. Day, M. Troetschel, O. Finn (2005)
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancerCancer Immunology, Immunotherapy, 54
P. Beatty, S. Narayanan, J. Gariépy, S. Ranganathan, O. Finn (2010)
Vaccine against MUC1 Antigen Expressed in Inflammatory Bowel Disease and Cancer Lessens Colonic Inflammation and Prevents Progression to Colitis-Associated Colon CancerCancer Prevention Research, 3
R. Graham, J. Burchell, J. Taylor‐Papadimitriou (1996)
The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccineCancer Immunology, Immunotherapy, 42
D. Cramer, A. Vitonis, Simone Pinheiro, J. McKolanis, R. Fichorova, K. Brown, T. Hatchette, O. Finn (2010)
Mumps and ovarian cancer: modern interpretation of an historic associationCancer Causes & Control, 21
F. Zhao, Sonja Obermann, R. Wasielewski, L. Haile, M. Manns, F. Korangy, T. Greten (2009)
Increase in frequency of myeloid‐derived suppressor cells in mice with spontaneous pancreatic carcinomaImmunology, 128
Lequn Li, V. Boussiotis (2011)
Molecular and functional heterogeneity of T regulatory cells.Clinical immunology, 141 3
B. Loveland, A. Zhao, S. White, H. Gan, K. Hamilton, P. Xing, G. Pietersz, V. Apostolopoulos, H. Vaughan, V. Karanikas, P. Kyriakou, I. McKenzie, P. Mitchell (2006)
Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with AdenocarcinomaClinical Cancer Research, 12
C. Tang, M. Katsara, V. Apostolopoulos (2008)
Strategies used for MUC1 immunotherapy: human clinical studiesExpert Review of Vaccines, 7
A. Silk, R. Schoen, D. Potter, O. Finn (2009)
Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer.Molecular immunology, 47 1
D. Nagorsen, E. Thiel (2006)
Clinical and Immunologic Responses to Active Specific Cancer Vaccines in Human Colorectal CancerClinical Cancer Research, 12
(2012)
Cancer Prev Res Cancer Prevention Research
S. Schuster, S. Neelapu, B. Gause, J. Janik, F. Muggia, J. Gockerman, J. Winter, C. Flowers, D. Nikcevich, E. Sotomayor, D. Mcgaughey, E. Jaffe, E. Chong, C. Reynolds, D. Berry, C. Santos, M. Popa, A. McCord, L. Kwak (2011)
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 20
R. Kanwar, Neha Singh, S. Gurudevan, J. Kanwar (2011)
Targeting hepatitis B virus and human papillomavirus induced carcinogenesis: novel patented therapeutics.Recent patents on anti-infective drug discovery, 6 2
M. Turner, J. McKolanis, R. Ramanathan, D. Whitcomb, O. Finn (2003)
Mucins in gastrointestinal cancers.Cancer chemotherapy and biological response modifiers, 21
J. Galon, A. Costes, F. Sánchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pagès, M. Tosolini, M. Camus, A. Berger, P. Wind, F. Zinzindohoué, P. Bruneval, P. Cugnenc, Z. Trajanoski, W. Fridman, F. Pagès (2006)
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 313
P. Kantoff, C. Higano, N. Shore, E. Berger, E. Small, D. Penson, C. Redfern, A. Ferrari, R. Dreicer, R. Sims, Yi Xu, M. Frohlich, P. Schellhammer (2010)
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.The New England journal of medicine, 363 5
A. Frey, N. Monu (2008)
Signaling defects in anti‐tumor T cellsImmunological Reviews, 222
L. Haile, R. Wasielewski, Jaba Gamrekelashvili, C. Krüger, O. Bachmann, A. Westendorf, J. Buer, R. Liblau, M. Manns, F. Korangy, T. Greten (2008)
Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.Gastroenterology, 135 3
Holmberg Sb, Ewing Sl, Montgomery Ck, Kim Ys (1996)
Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.Oncology Research, 8
T. Greten, M. Manns, F. Korangy (2011)
Myeloid derived suppressor cells in human diseases.International immunopharmacology, 11 7
Robert Schoen, P. Pinsky, J. Weissfeld, L. Yokochi, Timothy Church, A. Laiyemo, R. Bresalier, G. Andriole, S. Buys, E. Crawford, Mona Fouad, Claudine Isaacs, C. Johnson, D. Reding, B. O'Brien, Danielle Carrick, Patrick Wright, T. Riley, M. Purdue, G. Izmirlian, Barnett Kramer, Anthony Miller, J. Gohagan, P. Prorok, Christine Berg (2012)
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.The New England journal of medicine, 366 25
A. Silk, O. Finn (2007)
Cancer vaccines: a promising cancer therapy against all odds.Future oncology, 3 3
Hideaki Nakamura, Y. Hinoda, N. Nakagawa, Y. Makiguchi, F. Itoh, T. Endo, K. Imai (1998)
Detection of circulating anti-MUC1 mucin core protein antibodies in patients with colorectal cancerJournal of Gastroenterology, 33
G. Betts, E. Jones, S. Junaid, T. El-shanawany, M. Scurr, P. Mizen, Mayur Kumar, Sion Jones, Brian Rees, Geraint Williams, A. Gallimore, A. Godkin (2011)
Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancerGut, 61
K. Leung, P. Pinsky, A. Laiyemo, E. Lanza, A. Schatzkin, R. Schoen (2010)
Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study.Gastrointestinal endoscopy, 71 1
(2012)
2013 Cancer Prevention Research 24 Research. on April 9
G. Pecher, O. Finn (1996)
Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells.Proceedings of the National Academy of Sciences of the United States of America, 93 4
D. Schwartzentruber, D. Lawson, J. Richards, R. Conry, Donald Miller, J. Treisman, F. Gailani, L. Riley, K. Conlon, B. Pockaj, K. Kendra, R. White, Rene Gonzalez, T. Kuzel, B. Curti, P. Leming, E. Whitman, J. Balkissoon, D. Reintgen, H. Kaufman, F. Marincola, M. Merino, S. Rosenberg, P. Choyke, D. Vena, P. Hwu (2011)
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.The New England journal of medicine, 364 22
James Goydos, E. Elder, T. Whiteside, O. Finn, M. Lotze (1996)
A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma.The Journal of surgical research, 63 1
C. Butts, N. Murray, A. Maksymiuk, G. Goss, E. Marshall, D. Soulières, Y. Cormier, P. Ellis, A. Price, R. Sawhney, Mary Davis, J. Mansi, Colum Smith, D. Vergidis, P. Ellis, M. MacNeil, M. Palmer (2005)
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 27
S. Barratt-Boyes, A. Vlad, O. Finn (1999)
Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 7
Y. Ajioka, Hiroshi Watanabe, J. Jass (1997)
MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas.Journal of Clinical Pathology, 50
O. Finn, G. Forni (2002)
Prophylactic cancer vaccines.Current opinion in immunology, 14 2
Chien‐Ying Liu, Yu-Min Wang, Chihuei Wang, P. Feng, How-Wen Ko, Yun-hen Liu, Yi-cheng Wu, Y. Chu, F. Chung, C. Kuo, Kang-Yun Lee, Shu-Min Lin, Horng-Chyuan Lin, Chun-Hua Wang, Chih-Teng Yu, H. Kuo (2009)
Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancerJournal of Cancer Research and Clinical Oncology, 136
Robert Tacke, Hai‐Chon Lee, Celeste Goh, Jeremy Courtney, S. Polyak, H. Rosen, Y. Hahn (2012)
Myeloid suppressor cells induced by hepatitis C virus suppress T‐cell responses through the production of reactive oxygen speciesHepatology, 55
M. Reuschenbach, M. Doeberitz, N. Wentzensen (2009)
A systematic review of humoral immune responses against tumor antigensCancer Immunology, Immunotherapy, 58
K. Terry, L. Titus-Ernstoff, J. McKolanis, W. Welch, O. Finn, D. Cramer (2007)
Incessant Ovulation, Mucin 1 Immunity, and Risk for Ovarian CancerCancer Epidemiology Biomarkers & Prevention, 16
D. Gabrilovich, S. Nagaraj (2009)
Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 9
L. Sander, L. Sander, S. Sackett, U. Dierssen, N. Beraza, R. Linke, Michael Müller, J. Blander, F. Tacke, C. Trautwein (2010)
Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell functionThe Journal of Experimental Medicine, 207
T. Gilewski, S. Adluri, G. Ragupathi, Shengle Zhang, T. Yao, K. Panageas, M. Moynahan, A. Houghton, L. Norton, Philip Livingston (2000)
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 5
Szilvia Mosolits, G. Ullenhag, H. Mellstedt (2005)
Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results.Annals of oncology : official journal of the European Society for Medical Oncology, 16 6
H. Nishikawa, S. Sakaguchi (2010)
Regulatory T cells in tumor immunityInternational Journal of Cancer, 127
K. Jerome, N. Domenech, O. Finn (1993)
Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.Journal of immunology, 151 3
Cancer Prevention Research – Unpaywall
Published: Dec 18, 2012
Access the full text.
Sign up today, get DeepDyve free for 14 days.